Loading...
MAK logo

Maternus-Kliniken AktiengesellschaftXTRA:MAK Stock Report

Market Cap €21.2m
Share Price
€1.01
Future Cash Flow Value
n/a
1Y-28.9%
7D2.5%
Portfolio Value
View

Maternus-Kliniken Aktiengesellschaft

XTRA:MAK Stock Report

Market Cap: €21.2m

MAK Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Maternus-Kliniken Aktiengesellschaft Competitors

Price History & Performance

Summary of share price highs, lows and changes for Maternus-Kliniken
Historical stock prices
Current Share Price€1.01
52 Week High€1.80
52 Week Low€0.90
Beta0.29
1 Month Change1.51%
3 Month Change-8.18%
1 Year Change-28.87%
3 Year Change-33.55%
5 Year Change-74.49%
Change since IPO-90.76%

Recent News & Updates

Market Participants Recognise Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Revenues

Jul 27
Market Participants Recognise Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Revenues

Recent updates

Market Participants Recognise Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Revenues

Jul 27
Market Participants Recognise Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Revenues

Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Price Is Out Of Tune With Revenues

Jan 22
Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Price Is Out Of Tune With Revenues

Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) 25% Share Price Plunge Could Signal Some Risk

Aug 21
Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) 25% Share Price Plunge Could Signal Some Risk

Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Jul 05
Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price

Mar 13
A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price

Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around

Jul 27
Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around

The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence

Feb 22
The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence

Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital

Jul 27
Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital

Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)

Jun 10
Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)

Shareholder Returns

MAKDE HealthcareDE Market
7D2.5%-1.6%0.5%
1Y-28.9%16.7%14.8%

Return vs Industry: MAK underperformed the German Healthcare industry which returned 21.5% over the past year.

Return vs Market: MAK underperformed the German Market which returned 14.6% over the past year.

Price Volatility

Is MAK's price volatile compared to industry and market?
MAK volatility
MAK Average Weekly Movement5.7%
Healthcare Industry Average Movement6.7%
Market Average Movement5.2%
10% most volatile stocks in DE Market12.5%
10% least volatile stocks in DE Market2.5%

Stable Share Price: MAK has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: MAK's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18771,591n/awww.maternus.de

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes. The company offers rehabilitation clinics and various service companies that operate in the field of geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short- term and disability care services.

Maternus-Kliniken Aktiengesellschaft Fundamentals Summary

How do Maternus-Kliniken's earnings and revenue compare to its market cap?
MAK fundamental statistics
Market cap€21.18m
Earnings (TTM)-€13.41m
Revenue (TTM)€116.17m
0.2x
P/S Ratio
-1.6x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MAK income statement (TTM)
Revenue€116.17m
Cost of Revenue€91.97m
Gross Profit€24.21m
Other Expenses€37.62m
Earnings-€13.41m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.64
Gross Margin20.84%
Net Profit Margin-11.55%
Debt/Equity Ratio0%

How did MAK perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/15 11:11
End of Day Share Price 2026/01/15 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Maternus-Kliniken Aktiengesellschaft is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.